Stamford, CT -- (SBWIRE) -- 01/28/2014 -- Wall Street Pennies is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: Cannabis Science Inc (OTCMKTS:CBIS), Generex Biotechnology Corporation (OTCMKTS:GNBT), Cell Therapeutics Inc (NASDAQ:CTIC), BlackBerry Ltd (NASDAQ:BBRY).
Cannabis Science Inc (OTCMKTS:CBIS) opened its last trade at the price of $0.15. Its closing price was $0.189 after gaining 33.10% for the day. The company traded with the total volume of 57.06 million shares, while its average trading volume remained 34.09 million shares. The beta of this stock stands at 10.34. Cannabis Science, Inc., a development stage company, engages in the development, production, and commercialization of phytocannabinoid-based pharmaceutical products. It primarily focuses on developing medications to treat autism, blood pressure, cancer and cancer side effects, HIV, and other illnesses, including general health maintenance.
For How Long CBIS will Fight for Profitability? Read This Trend Analysis report
Generex Biotechnology Corporation (OTCMKTS:GNBT) percentage change plunged -12.28% to close at $0.0450 with the total traded volume of 18.13 million shares, along with average volume of 7.56 million shares. The 52 week range of the stock remained $0.02 - $0.07, while its day lowest price was $0.05. The share price hit the day highest price of $0.06. Generex Biotechnology Corporation, a development stage company, is engaged in the research, development, and commercialization of drug delivery systems and technologies for metabolic and immunological diseases.
Has GNBT Found The Bottom And Ready To Gain Momentum? Find Out Here
Cell Therapeutics Inc (NASDAQ:CTIC) traded on volume of 17.46 million shares in the last session against average volume of 5.96 million shares. The company started its trading session with the price of $3.79 and closed at $3.34 by scoring -16.50%. Cell Therapeutics, Inc. acquires, develops, and commercializes treatments for cancer. The company primary focuses on the commercialization of PIXUVRI, an aza-anthracenedione derivative, which is in Phase III clinical trials for the treatment of multiply relapsed or refractory aggressive non-Hodgkin lymphoma.
Why Should Investors Buy CTIC After the Recent Fall? Just Go Here and Find Out
BlackBerry Ltd (NASDAQ:BBRY) started its last trading session with the price of $9.69 and closed at $9.75 by scoring -1.42%. The stock traded with total volume of 270.83 million shares, while the average trading volume remained 35.37 million shares. The beta value of this stock stands at 1.40. Day range for the stock was $9.47 - $10.00. BlackBerry Limited engages in the design, manufacture, and marketing of wireless solutions worldwide. It provides platforms and solutions for access to email, voice, instant messaging, short message service, Internet and Intranet-based applications, and browsing through the development of integrated hardware, software, and services.
Will BBRY Get Buyers Even After The Recent Rally? Find Out Here
About Wall Street Pennies:
Wall Street Pennies is always penetrating the market every day for enormous penny stock runs before they happen in order to assist its customers. Our Penny Stock Newsletter also offers free market strategies and analysis from one of the most experienced and well-respected chartists in the penny stock industry.
Carriage Consulting Group, www.wallstreetpennies.com,, their Members, officers, directors, employees, affiliates, or any other related person(s) (collectively, “www.wallstreetpennies.com,”) are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. Wall Street Pennies as defined are neither licensed nor qualified to provide investment advice and you are specifically and adamantly advised not to rely upon anything said/posted/communicated/implied or expressed by www.wallstreetpennies.com, as defined.
Read full Disclaimer at: http://wallstreetpennies.com/financial-disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)